Zerion Pharma A/S: Financial statements 2019
CVR: 40169229
Source: annual report 2019, Danish Business Authority
14/01/2019 – 31/12/2019
Zerion Pharma A/S (CVR 40169229) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -1,068,242 and a net result of DKK -1,050,624. Equity in the 2019 report amounted to DKK 31,476. The solvency ratio was 3%. The company had 3 employees in the financial year.
- Gross Profit
- DKK -1,068,242
- Profit/Loss
- DKK -1,050,624
- Equity
- DKK 31,476
- Total Assets
- DKK 1,034,527
- Employees
- 3
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of October 10, 2019, Ole Sylvester-Hvid Wiborg has joined the board of directors of Zerion Pharma A/S.
As of October 10, 2019, Adam Jun Bohr has joined the board of directors of Zerion Pharma A/S.
As of October 10, 2019, Peter Mohan Christiansen has joined the board of directors of Zerion Pharma A/S.
As of October 10, 2019, Jorrit Jeroen Water has joined the board of directors of Zerion Pharma A/S.
As of October 10, 2019, Christian Bone Falk-Rønne has joined the board of directors of Zerion Pharma A/S.
As of October 10, 2019, Korbinian Arthur Maria Löbmann has joined the board of directors of Zerion Pharma A/S.
As of May 1, 2019, Mohan.dk ApS is registered as an owner of Zerion Pharma A/S with an ownership share of 5%.
As of February 25, 2019, WIBORG INTERNATIONAL HOLDING ApS is registered as an owner of Zerion Pharma A/S with an ownership share of 5%.
As of February 25, 2019, Waterman ApS is registered as an owner of Zerion Pharma A/S with an ownership share of 5%.
As of February 25, 2019, Running Man ApS is registered as an owner of Zerion Pharma A/S with an ownership share of 5%.
About Zerion Pharma A/S
Zerion Pharma A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Zerion Pharma ApS and Zerion ApS. The management consists of Ole Sylvester-Hvid Wiborg. The board consists of Carl-Åke Carlsson (chair), Geelanie Rodriguez Briones, Allan Stich and Dorte Juhl Arnbjerg. The company's owners include Geelanie Rodriguez Briones, WIBORG INTERNATIONAL HOLDING ApS and Waterman ApS. The company has 15 employees (2026). In 2025, the company reported revenue of DKK 3,377,646 and a net result of DKK -10,830,354 compared with DKK -220,020 the year before. Equity in the 2025 report amounted to DKK -3,511,410.